Agilon Health Reports Q2 2025 Results Amid Leadership Change

Agilon Health Inc ( (AGL) ) has released its Q2 earnings. Here is a breakdown of the information Agilon Health Inc presented to its investors.

Agilon Health Inc. is a company that partners with physicians to transform healthcare through a value-based Total Care Model, focusing on senior patients across the United States. The company operates in the healthcare sector, providing technology, capital, and a network to support independent physician practices.

In the second quarter of 2025, Agilon Health reported total revenues of $1.4 billion, with a Medicare Advantage membership of 498,000. The company is undergoing significant transitions, including a leadership change with the resignation of CEO Steven Sell and the appointment of co-founder Ronald A. Williams as Executive Chairman.

The financial results for the quarter showed a decrease in total revenue by 6% compared to the previous year, primarily due to market exits and reduced risk adjustment revenue. The company reported a net loss of $104 million, a negative medical margin of $53 million, and an adjusted EBITDA loss of $83 million. These results were influenced by strategic exits from certain markets and adjustments in risk revenue.

Agilon Health has suspended its full-year 2025 earnings guidance due to the leadership transition and ongoing strategic initiatives aimed at improving financial and clinical data visibility. The company is focused on enhancing its platform and operational discipline to better navigate dynamic market conditions.

Looking ahead, Agilon Health is optimistic about its strategic initiatives and expects to see financial improvements by 2026. The company aims to optimize its operations and capitalize on opportunities in the Medicare Advantage environment, with a focus on delivering long-term value for its physician partners and shareholders.